Two Sigma Advisers’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $366K | Sell |
108,500
-38,200
| -26% | -$129K | ﹤0.01% | 1884 |
|
|
2025
Q1 | $566K | Sell |
146,700
-87,200
| -37% | -$337K | ﹤0.01% | 1723 |
|
|
2024
Q4 | $1.44M | Sell |
233,900
-71,000
| -23% | -$438K | ﹤0.01% | 1282 |
|
|
2024
Q3 | $1.64M | Sell |
304,900
-95,200
| -24% | -$512K | ﹤0.01% | 1176 |
|
|
2024
Q2 | $1.34M | Sell |
400,100
-3,900
| -1% | -$13.1K | ﹤0.01% | 1401 |
|
|
2024
Q1 | $1.63M | Sell |
404,000
-181,000
| -31% | -$729K | ﹤0.01% | 1329 |
|
|
2023
Q4 | $1.55M | Buy |
585,000
+472,200
| +419% | +$1.25M | ﹤0.01% | 1423 |
|
|
2023
Q3 | $266K | Buy |
112,800
+33,800
| +43% | +$79.8K | ﹤0.01% | 2016 |
|
|
2023
Q2 | $498K | Buy |
79,000
+32,300
| +69% | +$203K | ﹤0.01% | 1809 |
|
|
2023
Q1 | $269K | Buy |
+46,700
| New | +$269K | ﹤0.01% | 2178 |
|